Company profile for Insilico Medicine

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Our Mission is to extend healthy longevity through innovative AI solutions for drug discovery and aging research. We aspire to be a leader in the field of deep learning for drug discovery, personalized healthcare, and anti-aging interventions. We developed a comprehensive drug discovery engine, which utilizes millions of samples and multiple data types to discover signatures of disease and identify the most promising targets f...
Our Mission is to extend healthy longevity through innovative AI solutions for drug discovery and aging research. We aspire to be a leader in the field of deep learning for drug discovery, personalized healthcare, and anti-aging interventions. We developed a comprehensive drug discovery engine, which utilizes millions of samples and multiple data types to discover signatures of disease and identify the most promising targets for billions of molecules that already exist or can be generated de novo with the desired set of parameters.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Hong Kong
Address
Address
Rm 8, Unit 111-113 ICT Co-Working Centre 1/F Enterprise Place, 5 Science Park ...
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercebiotech.com/biotech/lilly-continues-ai-push-inking-100m-plus-research-pact-insilico

FIERCE BIOTECH
10 Nov 2025

https://www.chemexpress.com/newsletter/ai-powered-adc-drug-development

PRESS RELEASE
22 Sep 2025

https://www.prnewswire.com/news-releases/insilico-medicine-launches-nach01-foundation-model-on-aws-marketplace-to-help-accelerate-generative-chemistry-innovation-302477524.html

PR NEWSWIRE
10 Jun 2025

https://www.prnewswire.com/news-releases/insilico-medicine-announces-nature-medicine-publication-of-phase-iia-results-evaluating-rentosertib-the-novel-tnik-inhibitor-for-idiopathic-pulmonary-fibrosis-ipf-discovered-and-designed-with-a-pioneering-ai-approach-302472070.html

PR NEWSWIRE
03 Jun 2025

https://www.prnewswire.com/news-releases/insilico-medicine-secures-110-million-series-e-financing-to-advance-ai-driven-drug-discovery-innovation-302401040.html

PR NEWSWIRE
13 Mar 2025

https://www.prnewswire.com/news-releases/harbour-biomed-and-insilico-medicine-achieve-strategic-collaboration-to-advance-ai-driven-antibody-discovery-and-development-302381211.html

PR NEWSWIRE
20 Feb 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty